Peters Richard
SEC insider (Form 3/4/5 filer). CIK 0001697628. Director at Aprea Therapeutics, Inc. (APRE) and 1 other issuer. 9 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in DOYLESTOWN, PA.
Companies Peters Richard has filed insider reports for
- Aprea Therapeutics, Inc. (APRE): Director
- KINETA, INC./DE (KA): Director
Peters Richard
CIK: 0001697628
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jun 16, 2026APRE
Aprea Therapeutics, Inc.
AwardDirect3.1K shares- - Mar 31, 2026APRE
Aprea Therapeutics, Inc.
PurchaseDirectPre-Funded Warrant
123.9K shares at avg. $0.81- - Mar 31, 2026APRE
Aprea Therapeutics, Inc.
PurchaseDirectCommon Warrant
123.9K shares- - Jun 30, 2025KANT
KINETA, INC./DE
DispositionDirect101.9K shares- - Jun 25, 2025KANT
KINETA, INC./DE
AwardDirect6K shares- - Jun 23, 2025KANT
KINETA, INC./DE
Tax PaymentDirect4.7K shares at avg. $0.26$1K - Jun 23, 2025KANT
KINETA, INC./DE
ExerciseDirect12.5K shares at avg. $0.61$8K - Jun 5, 2025APRE
Aprea Therapeutics, Inc.
AwardDirect1K shares- - Sep 4, 2024KA
KINETA, INC./DE
AwardDirectStock Option (Right to Buy)
12.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 |  APRE Aprea Therapeutics, Inc. | Award | 3,135 | - | $0 | Direct |
| Mar 31, 2026 | APRE Aprea Therapeutics, Inc. | Purchase Pre-Funded Warrant | 123,915 | $0.81 | - | Direct |
| Mar 31, 2026 | APRE Aprea Therapeutics, Inc. | Purchase Common Warrant | 123,915 | - | - | Direct |
| Jun 30, 2025 |  KANT KINETA, INC./DE | Disposition | 101,891 | - | - | Direct |
| Jun 25, 2025 | KANT KINETA, INC./DE | Award | 6,000 | - | - | Direct |
| Jun 23, 2025 | KANT KINETA, INC./DE | Tax Payment | 4,706 | $0.26 | $1,224 | Direct |
| Jun 23, 2025 | KANT KINETA, INC./DE | Exercise | 12,500 | $0.61 | $7,638 | Direct |
| Jun 5, 2025 | APRE Aprea Therapeutics, Inc. | Award | 1,045 | - | - | Direct |
| Sep 4, 2024 |  KA KINETA, INC./DE | Award Stock Option (Right to Buy) | 12,500 | - | - | Direct |
1-9 of 9 transactions